PATIENT ANALOG
HUMAN SIMULATION INFRASTRUCTURE
Animal Testing Ended. This Replaced It.
Tiny chips with living human cells, digital copies of your body.
Miniature organs grown in labs.
This is how we make medicine now.
The FDA made it official. We made it explorable.
Last Updated: February 2026
WHO ARE YOU?
The Definitive Platform for
FDA Modernization Act 3.0 & New Approach Methodologies
Organ-on-Chip · Organoids · Digital Twins · MPS · AI Drug Discovery
Free for everyone. Built for the future.
Organ-on-Chip
Digital Twin
BioLab
76+ interactive games and simulations exploring organ-on-chip, digital twins, and drug discovery
Explore simulations →Research
600+ pages covering organ-on-chip, organoids, digital twins, and regulatory science
Browse library →News
Live biotech headlines from research journals, industry, and regulatory agencies
Read latest →158 Premium Biotech Domains
Curated portfolio of high-value domains in organ-on-chip, organoids, digital twins, and emerging biotech.
✨ Share Your Story ✨Domain Portfolio Tiers
Flagship (4)
Category-defining brands with established traffic and market authority. Anchor assets of the portfolio.
Strategic (42)
Premium domains aligned to high-growth biotech verticals. Ideal for platform launches and brand acquisitions.
Standard (112)
Specialized domains spanning frontier biotech categories with strong keyword relevance and growth potential.
Explore the Complete Portfolio
View all 158 domains organized by category, market tier, and acquisition potential. Includes Arabic IDNs (Middle East market), Chinese IDNs (Asia-Pacific), and premium English domains.
💼 View Full PortfolioCore Technologies
Four pillars transforming drug discovery and reducing reliance on animal testing
Digital Twins
Virtual patient models for personalized drug response prediction
Organoids
3D tissue models derived from stem cells replicating organ function
Organ-on-Chip
Microfluidic devices simulating human organ physiology
AI & Machine Learning
Computational models accelerating drug discovery timelines
3D Visualization Lab
Explore interactive organoid and organ-on-chip models with real-time manipulation
Engage with cutting-edge human simulation technologies through our interactive 3D visualization laboratory. These models demonstrate the structural complexity of organoids and the engineering precision of organ-on-chip platforms.
Brain Organoid Model
Click & drag to rotate
Multi-Organ Chip Platform
6 organ chambers | Microfluidic flow visualization
Technology Gallery
Multi-Organ Microfluidic Chip
PDMS substrate with 6 interconnected organ chambers and continuous media flow
Brain Organoid Structure
Self-organizing 3D tissue with stem cells, neurons, and supporting cells
MPS Laboratory Setup
Incubator, confocal microscope, and microfluidic pump system
Virtual Patient Model
AI-powered digital twin with real-time organ simulation and drug response prediction
Neural Organoid Network
Multi-lineage organoids showing neural (cyan), hepatic (orange), and cardiac (pink) differentiation pathways
Organoid Culture Plate
Patient-derived organoids at various maturation stages - liver (brown), tumor (red), intestinal (orange), neural (white)
Intelligence Hub
curated research resources covering regulatory, scientific, and industry resources
Regulatory
FDA, NIH, EMA guidance and legislation including Modernization Act 2.0/3.0
45+ sourcesScientific
Organ-on-chip, organoids, digital twins, and MPS research platforms
120+ sourcesIndustry
Leading companies in human simulation technology and drug discovery
85+ sourcesAI & Compute
Quantum computing, machine learning, and computational biology resources
50+ sourcesOrgan-on-Chip
- Engineering liver organoids-on-a-chip for toxicity screeningFrontiers
- Lung-chip model recreates COPD inflammationNature
- Microfluidic platforms advance personalized medicineLab Chip
Organoid Research
- Brain organoids reveal autism gene functionCell
- Patient-derived organoids predict chemo responseScience
- Retinal organoids restore partial vision in trialsNature Med
Digital Twin
- Virtual patient models predict cardiac drug effectsSci Rep
- AI-powered digital twins enter clinical trialsTechCrunch
- DARPA funds next-gen human simulation platformDefense
Regulatory Updates
- FDA accepts first NAMs-only drug applicationFDA.gov
- EMA releases 3Rs implementation guidanceEMA
- NIH NCATS expands tissue chip program fundingNIH
Drug Discovery
- AI discovers novel antibiotic compound in 48 hoursNature
- Pfizer partners with organ-chip startupReuters
- Phase 3 trial uses organoid-guided dosingEndpoints
Industry News
- Emulate raises $82M Series E for organ-chipsTechCrunch
- Roche acquires AI drug discovery platformBioPharma
- Organoid biobank startup valued at $500MFierceBio
Science Lab Games
90+ educational games exploring biotech, organ-on-chip, and drug discovery
Explore Technologies
Comprehensive guides to the technologies transforming drug discovery and replacing animal testing
🩺 Organ-on-Chip Systems
Microfluidic devices replicating human organ physiology for drug testing
🧫 Organoids Complete Guide
3D miniature organs grown from stem cells for disease modeling
👥 Digital Twins in Healthcare
Virtual patient models for personalized drug response prediction
⚙ Microphysiological Systems
Advanced MPS platforms connecting multiple organ models
🧬 iPSC Technology
Induced pluripotent stem cells for patient-specific disease models
❤ Cardiac Models
Heart-on-chip and cardiac organoids for cardiotoxicity testing
🫀 Kidney Models
Nephron-on-chip systems for nephrotoxicity assessment
🫁 Liver Models
Hepatic organoids and liver chips for drug metabolism studies
⚖ New Approach Methodologies
NAMs framework replacing traditional animal testing
⚛ Quantum Drug Discovery
Quantum computing applications in molecular simulation
Applications
How organ-on-chip, organoids, and digital twins are revolutionizing medicine
💊 Drug Discovery
Accelerating pharmaceutical development with human-relevant models
⚠ Toxicity Testing
Safety assessment without animal testing using advanced models
🏥 Disease Modeling
Recreating human diseases in vitro for research breakthroughs
👥 Personalized Medicine
Patient-specific treatments using individual cell-derived models
🎯 Cancer Research
Tumor organoids and chips for oncology drug development
💎 Rare Diseases
Patient-derived models for orphan drug development
🦠 Infectious Diseases
Host-pathogen interaction studies and antiviral development
✨ Regenerative Medicine
Tissue engineering and cell therapy applications
💄 Cosmetics Testing
Cruelty-free skin and eye models for beauty industry
Regulatory Framework
Understanding the regulations enabling human-relevant testing methods
⚖️ FDA Modernization Act - Complete Guide
Comprehensive breakdown of the landmark legislation ending animal testing mandates
📜 FDA Modernization Act 3.0
Latest updates and implementation status
⚖ FDA iStand Program
Innovative Science and Technology Approaches for New Drugs
🇪🇺 EMA 3Rs Framework
European Medicines Agency replacement, reduction, refinement
🏛 EPA NAMs Strategy
Environmental Protection Agency new approach methodologies
🌐 ICH Guidelines
International harmonization of pharmaceutical regulations
🌍 OECD Test Guidelines
International standards for chemical safety testing
🏥 NCATS Tissue Chip
NIH tissue chip for drug screening program
🚀 ARPA-H Initiatives
Advanced Research Projects Agency for Health programs
Practical Guides
Hands-on protocols and procedures for implementing advanced testing methods
📖 Getting Started with Organoids
Beginner's guide to culturing your first 3D organoids
📋 Organ Chip Protocols
Setting up and operating microfluidic organ-on-chip devices
🧪 iPSC Differentiation
Protocols for differentiating induced pluripotent stem cells
💊 Drug Testing Methods
Standardized approaches for compound screening
📊 Biomarker Selection
Choosing and validating appropriate biomarkers
📊 Data Analysis
Statistical methods for MPS and organoid experiments
✅ Quality Assurance
QA/QC protocols for reliable reproducible results
📝 Regulatory Submission
Preparing NAMs data for FDA/EMA submissions
🔍 Vendor Selection
Evaluating and choosing MPS platform providers
Science Deep Dives
In-depth exploration of cutting-edge research topics
🔮 Organoid Types
💻 Chip Technologies
🔬 Advanced Topics
📋 Methods & Standards
Explore the Future of Medicine
Interactive simulations, live research feeds, and comprehensive resources for human-relevant drug discovery.
References
- Grand View Research. "Digital Health Market Size, Share & Trends Analysis Report By Technology, By Component, By End-use, By Region, And Segment Forecasts, 2023-2030." 2023. grandviewresearch.com
- Sun D, Gao W, Hu H, Zhou S. "Why 90% of clinical drug development fails and how to improve it?" Acta Pharmaceutica Sinica B. 2022;12(7):3049-3062. doi:10.1016/j.apsb.2022.02.002. PMID: 35865092.
- Grand View Research. "Organoids Market Size, Share & Trends Analysis Report By Type, By Application, By Source, By Region, And Segment Forecasts, 2023-2030." 2023. grandviewresearch.com
- U.S. Congress. "FDA Modernization Act 2.0" (S.5002 - 117th Congress). Signed into law December 29, 2022. congress.gov/bill/117th-congress/senate-bill/5002